FDA studying reports of liver failure… – Los Angeles Times

Posted by admin on August 24th, 2009 filed in General
6 FDA studying reports of liver failure... Los Angeles Times
Straits Times
FDA studying reports of liver failure... Los Angeles Times
FDA studying reports of liver failure with weight loss drug orlistat
Los Angeles Times
… in patients taking the weight-loss drug orlistat, sold as a prescription drug Xenical and more recently, as an over-the-counter medication called Alli. …
FDA probes liver damage with weight loss pill alliThe Associated Press
FDA concerned about two popular weight loss drugsBartlesville Live
FDA to probe liver damage reports from weight loss pills Alli and …Sawf News
eMaxHealth -Wall Street Journal -NBC Dallas-Fort Worth
all 249 news articles »

Source : weight loss – Google News
Click here for free articles and news on losing fats now

Popularity: 6% [?]

  • Share/Bookmark

del.icio.us:FDA studying reports of liver failure... - Los Angeles Times digg:FDA studying reports of liver failure... - Los Angeles Times spurl:FDA studying reports of liver failure... - Los Angeles Times wists:FDA studying reports of liver failure... - Los Angeles Times simpy:FDA studying reports of liver failure... - Los Angeles Times newsvine:FDA studying reports of liver failure... - Los Angeles Times blinklist:FDA studying reports of liver failure... - Los Angeles Times furl:FDA studying reports of liver failure... - Los Angeles Times reddit:FDA studying reports of liver failure... - Los Angeles Times fark:FDA studying reports of liver failure... - Los Angeles Times blogmarks:FDA studying reports of liver failure... - Los Angeles Times Y!:FDA studying reports of liver failure... - Los Angeles Times smarking:FDA studying reports of liver failure... - Los Angeles Times magnolia:FDA studying reports of liver failure... - Los Angeles Times segnalo:FDA studying reports of liver failure... - Los Angeles Times gifttagging:FDA studying reports of liver failure... - Los Angeles Times

Leave a Comment



Disclaimer: This site receives compensation if its users decide to purchase a third-party solution that's referred from this website